Singapore: With biosimilars promising an exponential growth, South Korea's Celltrion has filed an FDA application for Re...
Singapore: Britain's drug regulator, the UK Medicines and Healthcare Products Regulatory Agency has revoked the quality ...
Mumbai: Indian generic pharmaceuticals company Cipla appointed Mr Subhanu Saxena as its chief executive officer. Mr Saxe...
Singapore: Indian pharma major, Cipla recently announced that the company's wholly owned subsidiary Meditab holdings ent...
Singapore: Indian drug major Lupin has inked a marketing pact with South Korea's LG Life Sciences to launch its anti-di...
Singapore: British drug maker GlaxoSmithKline is in advanced talks to recruit Sir Philip Hampton, chairman of Royal Bank...
Singapore: India based generic drug maker Cipla has recieved FDA tentative approval for a generic formulation of emtrici...
Singapore: The US FDA has granted approval for the launch of Dr. Reddy's Laboratories's cancer drug Azacitidine for inje...
Singapore: India-based Aurobindo Pharma eyes on globalization and innovation to achieve a turnover of $2 billion in the...
Singapore: The birth of one of the largest generic pharmaceutical companies in South Korea just came about when Alvogen ...
Singapore: India's Aurobindo Pharma received final approval from the US FDA to manufacture and market Escitalopram Oxala...
Singapore: Canada has quarantined the health products made with active pharmaceutical ingredients (APIs) from India's Sr...
Singapore: Shanghai Fosun Pharmaceutical has been listed in CCTV Financial 50 Index Sample Stock, an index created by Sh...
Singapore: The US FDA has approved world's first generic version of Actos (pioglitazone hydrochloride) tablets. US-based...
The year 2011 was a year of capturing potential markets and achieving new milestones. Ranbaxy Laboratories became the fi...
Singapore: Interpol's sixth and the biggest annual worldwide crackdown, Pangea VI has ended in seizing of $41 million wo...
Singapore: Gilead have allowed generic manufacturers in India and China to produce generic versions of its HBV and HIV d...
Singapore: The Indian pharmaceutical industry is estimated to continue to experience strong growth in the near-term alth...
